Observational Study of BRAF Inhibitor Combination Therapy for BRAF mutant Metastatic Colorectal Cancer including Biomarker Research: BEETS trial(JACCRO CC-18)

ABSTRACT: Primary outcome(s): Overall survival Relationship between treatment outcomes of BRAF inhibitor combination therapy and genomic data on pretreatment ctDNA and RNA analysis

DISEASE(S): Colorectal Cancer

PROVIDER: 2661470 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR